ACM
PYXS icon

ADAR1 Capital Management’s Pyxis Oncology PYXS Stock Holding History

ADAR1 Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$15.6K – 241
2024
Q4 		$15.6K Hold
10,000
– – ﹤0.01% 202
2024
Q3 		$36.7K Hold
10,000
– – 0.01% 229
2024
Q2 		$33.1K Hold
10,000
– – 0.01% 203
2024
Q1 		$42.6K Buy
+10,000
New +$42.1K 0.01% 189

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ADAR1 Capital Management's PYXS Position: Q1 2025 in Review

ADAR1 Capital Management sold out of Pyxis Oncology (PYXS) in Q1 2025, closing a stake of 10,000 shares — an estimated $15.6K sold.

ADAR1 Capital Management first reported a position in PYXS in Q1 2024 and held it in 4 quarters. The position peaked at $42.6K in Q1 2024. 88 funds tracked by Wall St. Rank hold PYXS as of Q1 2025.

  • ADAR1 Capital Management reported no remaining Pyxis Oncology position as of Q1 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 10,000 Pyxis Oncology shares in Q1 2025, an estimated $15.6K.
  • ADAR1 Capital Management first reported a position in Pyxis Oncology in Q1 2024 and held it in 4 quarters.
  • ADAR1 Capital Management's Pyxis Oncology position peaked at $42.6K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2025.

Based on ADAR1 Capital Management's 13F filing for Q1 2025, filed 15 May 2025.